Robert W. Watkins

Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors. IV. Discovery of 1-[(4,6-Dimethyl-5-pyrimidinyl)carbonyl]- 4-[4-{2-methoxy-1(<i>R</i>)-4-(trifluoromethyl)phenyl}ethyl-3(<i>S</i>)-methyl-1-piperazinyl]- 4-methylpiperidine (Sch-417690/Sch-D), a Potent, Highly Selective, and Orally Bioavailable CCR5 Antagonist

Jayaram R. Tagat, Stuart W. McCombie, Dennis V. Nazareno et al. · Journal of Medicinal Chemistry · 2004 · 136 citations · Full text

Excellent Receptor Selectivity, Immunology, Hiv-1 Inhibitors +19

A total internal‐reflection technique for the examination of protein adsorption

Robert W. Watkins, Channing R. Robertson · Journal of Biomedical Materials Research · 1977 · 114 citations

The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs

Harry R. Davis, Kathyrn K. Pula, Kevin B. Alton et al. · Metabolism · 2001 · 93 citations

Oxysterol, 3-Hydroxy-3-methylglutaryl Coenzyme, Biochemistry +9

Potent Tetracyclic Guanine Inhibitors of PDE1 and PDE5 Cyclic Guanosine Monophosphate Phosphodiesterases with Oral Antihypertensive Activity

Ho-Sam Ahn, Ana Bercovici, George Boykow et al. · Journal of Medicinal Chemistry · 1997 · 80 citations · Full text

SCH 57790, a selective muscarinic M2 receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animals

Galen Carey, William Billard, Herbert Binch et al. · European Journal of Pharmacology · 2001 · 76 citations

Molecular Pharmacology, Laboratory Animals, Medicine +8